HCPCS Code B4197: Parenteral nutrition billing guide

Key Takeaways

HCPCS Code B4197 covers compounded parenteral nutrition solution with amino acids, carbohydrates, electrolytes, trace elements, and vitamins, premix, for patients requiring 74 to 100 grams of protein per day, regardless of fluid volume.

B4197 claims route to the DME MAC (not the Part A or Part B MAC), and Medicare Part B covers home parenteral nutrition only when GI tract dysfunction prevents adequate oral or enteral absorption.

CMS discontinued Certificates of Medical Necessity for dates of service on or after January 1, 2023; medical necessity is now supported by a physician order, nutritional assessment, and diagnosis retained in the medical record, not a submitted CMN.

Pabau’s claims management software helps IV therapy and infusion clinics automate documentation workflows, flag missing supporting documentation, and reduce B4197 claim denials before submission.

Most parenteral nutrition claim denials trace back to one problem: the wrong B-series code was selected because the coder didn’t verify the patient’s daily protein-gram tier before billing. HCPCS Code B4197 is defined by a single hard parameter, grams of protein per day, and getting that tier wrong sends the claim to the wrong code entirely.

IV therapy and infusion clinics billing home parenteral nutrition under Medicare need to confirm the patient’s premix formulation falls within the 74-to-100-gram protein-per-day tier before selecting B4197. Miss that threshold and B4193 (52 to 73 grams) or B4199 (over 100 grams) applies instead.

This guide covers the full B4197 code description, how it compares to adjacent B-series codes, Medicare coverage rules, medical necessity criteria, 2026 fee schedule data, applicable modifiers, ICD-10 crosswalk, and the billing errors that cause most denials.

B4197 full code description and key parameters

The official HCPCS Level II descriptor for B4197 is: Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 74 to 100 grams of protein – premix.

Breaking down every element of that descriptor matters for correct coding. The table below maps each component to its billing significance.

Per CMS’s HCPCS Level II code set, B4197 falls within the B-series covering enteral and parenteral nutrition supplies and solutions. The code is updated annually; verify the current year’s descriptor against the official CMS HCPCS code file before billing.

How B4197 compares to adjacent parenteral nutrition codes

The B4189-B4199 premix series for parenteral nutrition is tiered strictly by grams of protein per day, not fluid volume or number of bags. One unit of service represents one day’s supply of protein and carbohydrate regardless of how that volume is delivered. Selecting the wrong protein tier is the single most common reason for B4197 claims to be denied or down-coded.

Coders should verify the patient’s compounding pharmacy order against the daily protein-gram total before selecting a code, regardless of fluid volume or number of bags. A prescription specifying 74 to 100 grams of protein per day maps to B4197. When the protein total rises above 100 grams per day, the claim should move to B4199 instead. B4164, B4168, B4172, B4176, B4178, and B4180 are separate homemix component codes for dextrose or amino-acid concentration, billed per 500 mL unit; they are not volume tiers of B4197 and should not be selected as alternatives to it. Use the AAPC HCPCS code lookup to cross-reference descriptor language when in doubt.

Medicare coverage for HCPCS B4197

Medicare Part B covers home parenteral nutrition when the beneficiary’s GI tract cannot be used to absorb nutrients adequately. This is the foundational coverage rule, and it matters because B4197 is a DMEPOS item: claims route to the IV therapy billing team and are adjudicated by the DME MAC for the beneficiary’s jurisdiction, not the standard Part B MAC.

There are four DME MAC jurisdictions, administered by two contractors since a 2021 consolidation. Knowing which one handles a given claim determines where to send documentation and prior-authorization requests:

• Jurisdiction A (CT, DC, DE, MA, MD, ME, NH, NJ, NY, PA, RI, VT): Noridian Healthcare Solutions
• Jurisdiction B (IL, IN, KY, MI, MN, OH, WI): CGS Administrators
• Jurisdiction C (AL, AR, CO, FL, GA, LA, MS, NC, NM, OK, PR, SC, TN, TX, USVI, VA, WV): CGS Administrators
• Jurisdiction D (AK, AZ, CA, GU, HI, IA, ID, KS, MO, MT, ND, NE, NV, OR, SD, UT, WA, WY): Noridian Healthcare Solutions

Each DME MAC publishes its own Local Coverage Determinations (LCDs). The current LCD for parenteral nutrition is L38953, supported by Policy Article A58836; the prior LCD, L33798 (Policy Article A52515), was retired on November 12, 2020. Always verify the applicable LCD for the beneficiary’s jurisdiction before submitting. Per the CGS Medicare parenteral nutrition billing guidance, Medicare Part B covers home PN as a prosthetic device under the Medicare benefit, not as a drug benefit.

Medical necessity criteria for B4197 claims

Meeting the protein threshold is necessary but not sufficient for B4197 coverage. The patient must also have a documented clinical condition that prevents adequate GI absorption. CMS and applicable LCDs define the following categories of qualifying diagnoses:

• Massive small bowel resection: typically defined as retention of less than 5 feet of small intestine distal to the ligament of Treitz
• Short bowel syndrome: insufficient absorptive surface area after surgery
• Motility disorders: severe, clinically documented gastroparesis or intestinal pseudo-obstruction unresponsive to prokinetics
• Bowel obstruction: partial or complete obstruction anticipated to last more than 3 months
• Crohn’s disease or severe inflammatory bowel disease: where bowel rest is clinically required
• Malabsorption syndromes: documented failure of enteral absorption via oral or tube feeding attempts
• Radiation enteritis: where GI mucosa has been damaged and enteral nutrition is not feasible

A patient with any of these conditions who requires the 74-to-100-gram protein tier that defines B4197 meets the clinical threshold. The physician’s narrative in the medical record must connect the diagnosis to the inability to absorb nutrients enterally. Generic documentation such as “patient requires TPN” is insufficient.

Documentation requirements for B4197 claims

Missing or incomplete documentation is the leading cause of B4197 denials. Every claim must be supported by a complete documentation package before the first infusion is billed. CMS discontinued Certificates of Medical Necessity (CMNs) and DME Information Forms (DIFs), including CMS-10126, for dates of service on or after January 1, 2023, per CMS Special Edition article SE22002. Suppliers must not submit a CMN or DIF with a current claim; medical necessity is instead supported by documentation retained in the medical record and made available on request.

Required documents for B4197 Medicare claims:

• Physician order / prescription: written order from the treating physician identifying the PN formulation, protein content, volume, and frequency
• Nutritional assessment: completed by a registered dietitian or physician, documenting the patient’s caloric and protein requirements and the basis for the prescribed formulation
• Diagnosis codes: ICD-10-CM codes supporting GI dysfunction and medical necessity (see ICD-10 crosswalk section below)
• Medical records: history, physical examination, laboratory values (pre-albumin, albumin, weight), and documentation of failed or contraindicated enteral nutrition
• Compounding pharmacy prescription: the actual compound order showing amino acid concentration, dextrose percentage, additive content, and daily volume

Practices using digital intake and consent forms can template the medical necessity documentation and nutritional assessment fields to ensure nothing is missed at the point of care. The standard workflow for opening an IV therapy clinic typically includes setting up these documentation templates as part of the credentialing and billing setup process.

B4197 fee schedule and Medicare allowable rates (2026)

Medicare payment rates for B4197 are established under the DMEPOS fee schedule, updated annually. Rates vary by geographic locality based on CMS Geographic Practice Cost Indices (GPCI). The table below provides representative 2026 rate tiers; actual payments depend on the beneficiary’s state and the applicable DMEPOS fee schedule modifier.

Use the CMS fee schedule lookup tool to retrieve the current-year allowable rate for B4197 by locality. Rates are expressed as per-day amounts; multiply by days of service when billing a monthly supply. Verify current year rates before submitting claims, as DMEPOS fee schedule amounts are updated each January 1.

Reduce HCPCS billing errors with Pabau

Pabau's claims management tools help IV therapy and infusion clinics automate documentation workflows, catch missing supporting documentation before submission, and track claim status across DME MAC jurisdictions. See how it works for your clinic.

Book a demo

Applicable modifiers for B4197

Modifier usage with B4197 depends on whether the claim involves a single-drug bag or a multi-drug parenteral nutrition bag. Most home PN formulations are multi-drug compounded solutions, which triggers the KO/KP/KQ modifier set. According to CGS Medicare’s parenteral nutrition billing guidance, these modifiers are used when a single infusion bag contains two or more separately billed drugs.

The KP/KQ modifier rules for multi-drug compounded PN bags are noted as “likely” in DME MAC guidance but involve nuanced billing scenarios not always covered in national CMS manuals. Verify the applicable modifier combinations against your DME MAC’s local billing instructions before submitting. The best EMR systems for IV therapy include modifier validation rules to catch these combinations before claims are submitted to the DME MAC.

ICD-10 codes that support medical necessity for B4197

Every B4197 claim must include ICD-10-CM diagnosis codes that directly support the medical necessity for home parenteral nutrition. The following codes are among those cited in CMS and LCD documentation as supporting medical necessity. This list is not exhaustive: verify the complete list against the applicable jurisdiction’s LCD before billing.

Clinics managing infusion patients can link ICD-10 diagnosis codes directly to treatment documentation through Pabau’s claims management software, which maps diagnosis codes to the corresponding HCPCS billing codes during the pre-submission review. For additional ICD-10 crosswalk guidance, the PGM Billing HCPCS lookup tool provides free code search with diagnosis crosswalk functionality.

Common billing errors and how to avoid them

B4197 has a higher denial rate than many DMEPOS codes because its narrow protein-gram tier and documentation requirements create multiple ways to select the wrong code or submit an incomplete claim. Practices billing home and mobile IV therapy should train billing staff on all of the following error patterns.

• Confusing adjacent protein tiers: Coders round the daily protein total instead of checking the exact gram figure. A prescription of 100.5 grams of protein per day requires B4199, not B4197, even though the two codes look similar.
• Submitting an outdated CMN or DIF: CMS discontinued Certificates of Medical Necessity and DME Information Forms for dates of service on or after January 1, 2023. Attaching one to a current claim can get it rejected or returned rather than approved.
• No documentation of failed enteral nutrition: LCDs require evidence that enteral nutrition was tried and failed or is contraindicated. Missing this note is among the top denial triggers.
• Incorrect DME MAC routing: Submitting a B4197 claim to the Part B MAC rather than the beneficiary’s DME MAC will result in rejection. Verify jurisdiction assignment before submission.
• Modifier omission on multi-drug bags: Failing to append KP to the first drug code in a multi-drug compounded bag, or applying KQ without a corresponding KP, triggers edit-level rejections.
• Billing frequency mismatches: B4197 is typically billed per day of service. Submitting a monthly total without units, or billing units as a lump sum, generates claim edits.
• Unbundling additive codes incorrectly: Trace elements, vitamins, and electrolytes are included in the B4197 descriptor. Separately billing additive HCPCS codes for components already bundled into B4197 creates overpayment risk and audit exposure.

How practice management software streamlines B4197 billing

Compounded parenteral nutrition reimbursement depends on clean claims, and clean claims depend on documentation that is complete before the infusion starts, not chased after denial. Most B4197 errors are documentation gaps, not coding errors.

Practice management platforms with built-in claims management help infusion practices close those gaps systematically. Before a B4197 claim is submitted, the software can flag missing supporting documentation, verify that the diagnosis code on file supports the HCPCS code selected, and confirm that modifier KP or KO is appended for the correct bag type. This is the same workflow that EHR integration frameworks enable: the clinical record, the physician order, and the billing code all reference the same patient encounter.

Practices using automated clinical workflows can build rule-based triggers that alert billing staff when a parenteral nutrition order lacks the required supporting documentation before the claim window opens. For clinics managing recurring home PN patients, similar documentation-driven billing patterns apply across other infusion and procedure code types.

Conclusion

HCPCS Code B4197 is one of the more complex DMEPOS billing codes because correct selection depends on the exact daily protein-gram tier, documentation must be complete before submission, and claims route through the DME MAC rather than the standard Part B MAC. A single missed gram threshold or an incomplete medical record sends the claim to the wrong code or generates a denial.

Pabau’s claims management software helps infusion and IV therapy practices automate the pre-submission checklist, map diagnosis codes to HCPCS billing codes, and reduce denial rates on complex codes like B4197. To see how it works for your clinic, book a demo.

Continue your research

Running an IV therapy or infusion practice? IV therapy EMR software from Pabau covers documentation, scheduling, and billing workflows built for infusion clinics.

Need guidance on opening an infusion clinic? How to open an IV therapy clinic walks through licensing, staffing, documentation setup, and billing requirements.

Looking for best practices across IV therapy operations? IV therapy clinic best practices covers patient intake, consent, and documentation workflows that support cleaner DMEPOS claims.

Frequently Asked Questions